Search for: "Apotex"
Results 421 - 440
of 1,051
Sorted by Relevance
|
Sort by Date
6 Aug 2007, 8:38 pm
Apotex; Ortho-McNeil v. [read post]
15 Feb 2010, 8:11 am
Of the several reasons cited, the Court approved the district court's rationale for avoiding a potentially unnecessary round of discovery: "In this case, the Delaware District Court ruled that 'substantial, unresolved questions remain with regard to whether this District has personal jurisdiction over Defendant Apotex . . . ' and stated that it would not exercise jurisdiction over Apotex without jurisdictional discovery. [read post]
29 Feb 2008, 7:04 pm
Dow Jones reported Monday that Apotex and Pfizer settled their patent litigation over generic Neurontin (gabapentin). [read post]
4 Dec 2013, 4:34 am
Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50 (4 December 2013)A panel of five judges of the High Court has decided, by a majority of 4-1, that methods of treating the human body by the administration of a therapeutic drug constitute patent-eligible subject matter in Australia. [read post]
11 Sep 2013, 7:07 am
Apotex, Inc., et. al. v. [read post]
10 Jun 2022, 10:38 am
Apotex Corp., 439 F.3d 1312, 1320 (Fed. [read post]
31 Jan 2015, 8:47 pm
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]
1 Mar 2015, 4:51 am
A judge of the Federal Court of Australia has denied a request by patentee Les Laboratoires Servier (‘Servier’) to amend a patent in order to avoid cancellation for failure to disclose the best method of performing the claimed invention solely because it opted not to follow a recommendation made by its Australian patent attorneys during examination of the original application back in 2004: Apotex Pty Ltd v Les Laboratoires Servier (No 4) [2015] FCA 104.Just be absolutely clear… [read post]
9 Aug 2016, 7:50 am
Apotex Inc., - F.3d - (Fed. [read post]
30 Jan 2015, 10:52 am
Lucy F Reed & James Freda, Maxwell Lecture: After ICCA Singapore, After ICCA Miami: The Next QuestionsCase CommentsCharles T Kotuby, Jr & James Egerton-Vernon, Apotex Inc v The Government of the United States of America: Will Barriers to Jurisdiction Inhibit an Emerging Trend? [read post]
21 Dec 2015, 5:43 pm
Apotex, Inc., 633 F.3d 1042, 1050 (Fed. [read post]
5 Jul 2016, 11:16 am
Apotex ’s proposed inference from (9)(B) would implicitly make (8)(A) neither mandatory nor standalone, despite (8)(A)’s language, and would reintroduce the very problems of rushed litigation —over patents the applicant is empowered to prevent being litigated earlier—that (8)(A) was enacted to avoid.The inference that Congress rendered unavailable direct injunctive enforcement of (8)(A)’s plain terms is unwarranted. [read post]
19 Dec 2012, 8:51 pm
Apotex, lnc., 470 F.3d 1368, 1374 (Fed. [read post]
27 Aug 2014, 1:35 am
Apotex Corp., 316 F.3d1348, 1365 (Fed. [read post]
25 Sep 2022, 6:00 pm
Brandon Heard: Ontario Court of Appeal Affirms Dismissal of Apotex’s Statutes of Monopolies and Trademarks Act Claims Regarding Olanzapine (Source: JD Supra) Samantha Handler: Apple Patent Victories Upheld by Tribunal After Arthrex Remand (Source: Bloomberg Law) Blake Brittain: Ex-Patent Officials, U.S. [read post]
26 Jul 2014, 9:14 pm
Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
19 Feb 2024, 12:55 pm
Teva and Apotex, filed Abbreviated New Drug Applications (ANDAs) with the FDA seeking to market generic versions of the $100m+ drug. [read post]
16 Dec 2008, 11:47 pm
Apotex (07-1438). [read post]
21 May 2007, 8:53 am
This is the SSRI case out of the Eastern District of Pennsylvania in which the court found most claims preempted both against a generic and against a pioneer drug manufacturer. [read post]
24 Mar 2023, 5:15 pm
This month there were two new recalls for eyedrops distributed by Pharmedica and Apotex. [read post]
